Target intelligence / Profile preview

Neutrophil cytosol factor 4 (NCF4)

Target
NCF4
Molecular classification
Enzyme complex subunit, Oxidoreductase complex component, Other (adapter/regulatory protein)
01

Overview

Neutrophil cytosol factor 4 (NCF4, commonly referred to as p40-phox) is a regulatory cytosolic subunit of the phagocyte NADPH oxidase (NOX2) complex, which is critical for innate immune defense. NCF4 is primarily expressed in myeloid cells and facilitates the assembly and activation of the NADPH oxidase complex by interacting with other cytosolic subunits (NCF1/p47-phox, NCF2/p67-phox) and membrane-bound components. Upon stimulation, the complex assembles at the membrane and enables electron transfer from NADPH to molecular oxygen, producing superoxide and downstream reactive oxygen species (ROS) that are essential for the destruction of pathogens by phagocytes. NCF4’s PX domain directs the complex to specific cellular compartments by binding characteristic membrane phospholipids. Mutations in NCF4 can impair ROS production, leading to increased susceptibility to infections (as seen in chronic granulomatous disease) and contribute to autoimmune and inflammatory diseases due to its role in immune regulation, particularly affecting B cell development and inflammatory responses[1][2][3][4][5].

Other names
p40-phoxp40phoxNeutrophil cytosolic factor 4Neutrophil cytosol factor 4, 40kDaNeutrophil NADPH oxidase factor 4NCF-4SH3 and PX domain-containing protein 4SH3PXD4NCF4_HUMAN
02

Mechanism of action

Inhibition of NADPH oxidase reduces ROS production, decreasing phagocyte microbial killing and modulating immune function[2].

03

Biological functions

Immune responseHost defenseGeneration of reactive oxygen speciesInflammation regulationB cell differentiation
04

Disease associations

Chronic granulomatous diseaseAutoimmune disease (e.g., rheumatoid arthritis, collagen-induced arthritis)InflammationCrohn's diseaseOther (increased infection susceptibility)
05

Safety considerations

NADPH oxidase inhibitors could increase infection risk due to impaired microbial killing by phagocytes[3].Rare NCF4 mutations may cause immunodeficiency and excessive inflammation[3].
06

Interacting drugs

None reported specific to NCF4; NOX2 complex inhibitors (e.g., GSK2795039, used experimentally) regulate the whole NADPH oxidase complex[2].
07

Biomarkers

Genetic variants (e.g., SNPs such as rs4821544) in NCF4 correlate with Crohn’s disease risk and ROS response defects[1].Mutations can be tested as part of chronic granulomatous disease genetic screening[3].

Beyond the preview

Go deeper on Neutrophil cytosol factor 4 (NCF4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neutrophil cytosol factor 4 (NCF4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call